Ilsa Kirby

Ilsa Kirby has a diverse work experience in the fields of scientific research and legal assistance. Ilsa began their career as a Research Assistant at Reed College, where they conducted independent research on organic synthesis. Following this, they worked as a Laboratory TA, where they supervised and assisted students in Organic Chemistry laboratories.

In 2013, Ilsa joined Peterson Wampold Rosato Feldman Luna as a Legal Assistant, supporting trial preparation and managing trial technology. Ilsa was responsible for developing graphic and multimedia trial exhibits and conducting case-specific jury research.

Ilsa's scientific research experience includes their role as a Graduate Student Researcher at Oregon Health and Science University. Here, they focused on designing inhibitors for poly ADP-ribose polymerases (PARPs) and developed a family-wide screening assay for PARP inhibitors. Ilsa also collaborated with other researchers for crystallography studies.

From 2019 to 2021, Ilsa worked as a Postdoctoral Researcher at the University of California, San Francisco. In the Shokat lab, they contributed to the discovery of small molecule tools and drug candidates targeting protein/lipid kinases, GTPases, and RNA helicases. Ilsa'sresearch interests revolved around developing small molecule translational inhibitors of oncogenic proteins.

Currently, Ilsa Kirby is a Scientist at Initial Therapeutics, where they continue their work in scientific research. The concise way to summarize their work experience is that Ilsa Kirby has worked in various research roles, specializing in the design and development of inhibitors for specific proteins and enzymes in the field of oncology. Ilsa also gained legal assistance experience in trial preparation and technology management.

Ilsa Kirby pursued their education by acquiring a Bachelor's Degree in Chemistry from Reed College, where they attended from 2009 to 2013. Following this, they furthered their studies at Health and Science jobs, specializing in Chemical Biology and obtaining a Doctor of Philosophy (Ph.D.) between 2014 and 2019.